|
CN104739804A
|
|
Antiviral drug tenofovir disoproxil fumarate solid preparation and preparation method thereof
|
|
CN103655499A
|
|
Stable X-crystal-shaped agomelatine tablet and preparation method thereof
|
|
CN104725430A
|
|
Industrial production method of miriplatin
|
|
CN103690499A
|
|
Stable crystalline form I agomelatine tablets and preparation method thereof
|
|
CN104721828A
|
|
Medicinal composition for improving stability of crystal medicines, and preparation method thereof
|
|
CN104422736A
|
|
Method for determining residual allyl amine in Sevelamer carbonate
|
|
CN102942501A
|
|
Production method for preparing agomelatine through hydrogenation
|
|
CN103864846A
|
|
Preparation method of tenofovir isopropyl isoproxil
|
|
CN103864972A
|
|
Preparation method of sevelamer carbonate
|
|
CN103630615A
|
|
Improved method for measuring topiramate related substances
|
|
CN103626736A
|
|
Preparation method of imatinib mesylate alpha-crystal form
|
|
CN102702033A
|
|
Amorphous peramivir, preparation method thereof and medicinal composition
|
|
CN102499908A
|
|
Alvimopan solid preparation and preparation method thereof
|
|
CN103159641A
|
|
Method for preparing intermediate 2-carboxylic acid-5-(2-methyl-benzoylamino)toluene for tolvaptan
|
|
CN102491995A
|
|
Method for preparing 9-[2-(R)-[[bis[[(isopropoxycarbonyl) oxy]methoxy]phosphoryl]methoxy]propyl]adenine monoester
|
|
CN102516040A
|
|
Industrialized production method of phenylalkyl chloromethyl ether
|
|
WO2013029199A1
|
|
Adefovir monoester and preparation method thereof
|
|
WO2013029198A1
|
|
Adefovir dipivoxil solid formulation and preparation method therefor
|
|
CN102558262A
|
|
Preparation method of high-purity capecitabine
|
|
CN102552268A
|
|
Medicinal preparation containing crystal form a imatinib mesylate
|
